Abstract
Background
Peritoneal metastasis is recognized as a predictor of poor prognosis in patients with colorectal cancer, and whether surgical intervention for peritoneal metastasis has any clinical benefit has remained controversial. The purposes of this study were to identify prognostic factors in cases of unresectable colorectal cancer with synchronous peritoneal metastasis and to clarify the impacts of primary tumor resection with high tie lymph node dissection.
Methods
A multi-institutional retrospective analysis was conducted of 579 patients who underwent resection of the primary tumor for unresectable colorectal cancer with peritoneal metastasis between 1991 and 2007. For these 579 patients, clinicopathological variables were analyzed for prognostic significance using Cox proportional hazards model and propensity score analysis to mitigate the selection bias.
Results
Multivariate analysis revealed hematogenous metastasis (p < 0.001), histology of the tumor (p = 0.006), postoperative chemotherapy (p < 0.001), and lymph node dissection (p = 0.001) as independent prognostic factors. In the propensity-matched cohort, patients treated with high tie lymph node dissection showed a significantly better overall survival than those with low tie lymph node dissection (median overall survival 13.0 vs. 11.5 months; p = 0.041).
Conclusions
It is suggested that primary tumor resection with high tie lymph node dissection favorably affects survival, even in unresectable colorectal cancer with peritoneal metastasis.
Similar content being viewed by others
References
Kotake K, Honjo S, Sugihara K et al (2003) Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan. Dis Colon Rectum 46:S32–S43
Muto T, Kotake K, Koyama Y (2001) Colorectal cancer statistics in Japan: data from JSCCR registration, 1974–1993. Int J ClinOncol 6:171–176
Jayne DG, Fook S, Loi C et al (2002) Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89:1545–1550
Kobayashi H, Enomoto M, Higuchi T et al (2010) Validation and clinical use of the Japanese classification of colorectal carcinomatosis: benefit of surgical cytoreduction even without hyperthermic intraperitoneal chemotherapy. Dig Surg 27:473–480
Kobayashi H, Kotake K, Funahashi K et al (2014) Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis. J Gastroenterol 49:646–654
Clancy C, Burke JP, Barry M et al (2014) A meta-analysis to determine the effect of primary tumor resection for Stage IV colorectal cancer with unresectable metastases on patient survival. Ann Surg Oncol 21:3900–3908
Venderbosch S, de Wilt JH, Teerenstra S et al (2011) Value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature. Ann Surg Oncol 18:3252–3260
Japanese Society for Cancer of the Colon and Rectum (2009) Japanese classification of colorectal carcinoma, Second English edn. Kanehara & Co., Ltd., Tokyo
West NP, Kobayashi H, Takahashi K et al (2012) Understanding optimal colonic cancer surgery. Comparison of Japanese D3 resection and European complete excision with central vascular ligation. J Clin Oncol 30:1763–1769
Poultsides GA, Servais EL, Saltz LB et al (2009) Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 27:3379–3384
Nitzkorski JR, Farma JM, Watson JC et al (2011) Outcome and natural history of patients with stage IV colorectal cancer receiving chemotherapy without primary tumor resection. Ann Surg Oncol 19:379–383
Ishihara S, Hayama T, Yamada H et al (2014) Prognostic impact of primary tumor resection and lymph node dissection in stage IV colorectal cancer with unresectable metastasis: a propensity score analysis in a multicenter retrospective study. Ann Surg Oncol 21:2949–2955
Hohenberger W, Weber K, Matzel K et al (2009) Standardized surgery for colonic cancer: complete mesocolic excision and central ligation––technical notes and outcome. Colorectal Dis 11:354–364
Deng L, Zhang H, Luan Y et al (2010) Accumulation of Foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients. Clin Cancer Res 16:4105–4112
Acknowledgments
The authors would like to express their sincere gratitude to the following researchers for collecting data: Kimihiko Funahashi, MD, Department of Surgery, Toho University; Kazuo Hase, MD, Department of Surgery, National Defense Medical College; Yojiro Hashiguchi, MD, Department of Surgery, Teikyo University; Tsuneo Iiai, MD, Department of Surgery, Niigata University; Shingo Kameoka, MD, Second Department of Surgery, Tokyo Women’s Medical University; Yukihide Kanemitsu, MD, and Koji Komori, MD, Department of Gastroenterological Surgery, Aichi Cancer Center Hospital; Koutarou Maeda, MD, Department of Surgery, Fujita Health University; Akihiko Murata, MD, Department of Surgery, Hirosaki University; Masayuki Ohue, MD, Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases; Kazuo Shirouzu, MD, Department of Surgery, Kurume University, Keiichi Takahashi, MD, Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital; Toshiaki Watanabe, MD, Department of Surgical Oncology, University of Tokyo; Hideaki Yano, MD, Department of Surgery, National Center for Global Health and Medicine; and Toshimasa Yatsuoka, MD, Department of Surgery, Saitama Cancer Center.
Conflict of interest
All authors declare that they have no conflict of interest in this manuscript.
Author information
Authors and Affiliations
Consortia
Corresponding author
About this article
Cite this article
Furuhata, T., Okita, K., Nishidate, T. et al. Oncological benefit of primary tumor resection with high tie lymph node dissection in unresectable colorectal cancer with synchronous peritoneal metastasis: a propensity score analysis of data from a multi-institute database. Int J Clin Oncol 20, 922–927 (2015). https://doi.org/10.1007/s10147-015-0815-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-015-0815-6